Analyst firms · Citigroup · HIMS
Citigroup HIMS price target and rating history
Hims & Hers Health Inc. (HIMS) · Health Care
Citigroup rates Hims & Hers Health Inc. (HIMS) Neutral with a $24 price target, as of its latest action on Mar 10, 2026. It has published 4 rating actions on HIMS since December 2021, including 1 upgrade and 2 downgrades. Across 5 firms with a HIMS price target in the last 12 months, the median target is $33. Citigroup's $24 is 27% below that.
- Current rating
- Neutral
- Price target
- $24
- Median target, all firms
- $33
- Actions on HIMS
- 4
Citigroup price target on HIMS
Every Citigroup rating on HIMS
- Mar 10, 2026
- Jan 10, 2025
- May 22, 2024
- Dec 20, 2021
How other firms rate HIMS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Needham | Buy | $35 | May 12, 2026 |
| Citigroup | Neutral | $24 | Mar 10, 2026 |
| BofA Securities | Neutral | $23 | Mar 10, 2026 |
| BTIG | Neutral | Feb 24, 2026 | |
| Evercore ISI | In-line | $33 | Jan 12, 2026 |
| Barclays | Overweight | $48 | Dec 9, 2025 |
Questions about Citigroup and HIMS
- What is Citigroup's price target for HIMS?
- Citigroup's latest stated price target for Hims & Hers Health Inc. (HIMS) is $24, from its action on Mar 10, 2026.
- What is Citigroup's rating on HIMS?
- Citigroup rates HIMS Neutral, a neutral rating, as of Mar 10, 2026.
- When did Citigroup last change its view on HIMS?
- On Mar 10, 2026, Citigroup upgrades to Neutral from Sell, price target $24.
- How does Citigroup's HIMS target compare with other analysts?
- Across 5 firms with a HIMS price target in the last 12 months, the median target is $33. Citigroup's $24 is 27% below that.
More HIMS rating histories
All Citigroup ratingsHIMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.